Jagsonpal Pharmaceuticals (BOM:507789) Short Interest


BOM:507789 Jagsonpal Pharmaceuticals Ltd BOM:507789
62 GF Score
Price ₹235.20
GF Value ₹205.07
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jagsonpal Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:507789 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jagsonpal Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jagsonpal Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jagsonpal Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Jagsonpal Pharmaceuticals's Short Interest falls into.


BOM:507789
62GF Score
Jagsonpal Pharmaceuticals Ltd BOM:507789
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jagsonpal Pharmaceuticals (BOM:507789) Overvalued in 2026?

Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals stock appears to be overvalued. The current stock price of ₹235.20 is trading 14.7% above its estimated GF Value™ of ₹205.07. GuruFocus considers Jagsonpal Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:507789:

  • Short Interest:
  • GF Value™: ₹205.07 vs. price of ₹235.20 (14.7% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BOM:507789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jagsonpal Pharmaceuticals Business Description

Other Exchanges JAGSNPHARM:India
Address 3rd Floor, Phase - IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
62GF Score

Get the complete analysis for BOM:507789

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹235.20
Price
₹205.07
GF Value